SCHEMBL1650436

SCHEMBL1650436

O=C(O)CN1CCSC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1373372 0.98 HSD17B10 (0.42)
SCHEMBL4768884 0.86 HSD17B10 (0.52)
Hydrochloric Acid SCHEMBL1371867 0.84 HSD17B10 (0.50)
SCHEMBL1007971 0.80
SCHEMBL5322238 0.80
SCHEMBL7428460 0.75 CYP1A2 (0.55)
SCHEMBL27554373 0.74
SCHEMBL9036691 0.74 ALDH1A1 (0.55)
Tetraxetan SCHEMBL18018 0.72 HSD17B10 (0.64)
SCHEMBL173508 0.72 HSD17B10 (0.64)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7705052-B2 Sulfonamide derivatives for the treatment of diabetes MERCK SERONO SA (CH) 2010-04-27 US claimed
CN-119737179-A Magnetically-expanded self-fastening anchor rod material and preparation method thereof 中煤科工开采研究院有限公司 2025-04-01 CN disclosed
CN-117624074-A Preparation method of high-purity epalrestat A crystal form 哈药集团技术中心 2024-03-01 CN disclosed
CN-116003604-A Epithelial cadherin-specific antibodies 科凌生物医疗有限公司 2023-04-25 CN disclosed
CN-115066439-A Epithelial cadherin-specific antibodies 科凌生物医疗有限公司 2022-09-16 CN disclosed
CN-114907286-A Preparation method of high-purity epalrestat crystal 山东达因海洋生物制药股份有限公司 2022-08-16 CN disclosed
US-20140107116-A1 BENZOTHIAZOLE DERIVATIVES FOR THE TREATMENT OF DIABETES MERCK SERONO SA (CH) 2014-04-17 US disclosed
WO-2011149841-A1 SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-α MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2011-12-01 WO disclosed
EP-1656139-B1 ARYL DICARBOXAMIDES MERCK SERONO SA (CH) 2011-10-05 EP disclosed
EP-1470102-B1 SUBSTITUTED METHYLENE AMIDE DERIVATIVES AS MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) MERCK SERONO SA (CH) 2011-05-25 EP disclosed
WO-2005025567-A1 BENZOTHIAZOLE DERIVATIVES FOR THE TREATMENT OF DIABETES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-03-24 WO disclosed
WO-2005025558-A1 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES APPLIED RESERACH SYSTEMS ARS HOLDING N.V. (AN) 2005-03-24 WO disclosed
WO-2005012280-A1 ALKYNYL ARYL CARBOXAMIDES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-02-10 WO disclosed
WO-2005011685-A1 ARYL DICARBOXAMIDES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2005-02-10 WO disclosed
EP-1470102-A1 SUBSTITUTED METHYLENE AMIDE DERIVATIVES AS MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) Applied Research Systems ARS Holding N.V. (AN) 2004-10-27 EP disclosed
WO-2003064376-A1 SUBSTITUTED METHYLENE AMIDE DERIVATIVES AS MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2003-08-07 WO disclosed
EP-1313471-A1 BENZYLIDENE THIAZOLIDINEDIONES AND THEIR USE AS ANTIMYCOTIC AGENTS Oxford GlycoSciences (UK) Limited (GB) 2003-05-28 EP disclosed
US-20020198201-A1 Combination of a PTPase inhibitor and an aldose reductase inhibitor WYETH 2002-12-26 US disclosed
WO-2002098510-A1 COMBINATION OF A PTPASE INHIBITOR AND AN ALDOSE REDUCTASE INHIBITOR WYETH (US) 2002-12-12 WO disclosed
WO-2002017915-A1 BENZYLIDENE THIAZOLIDINEDIONES AND THEIR USE AS ANTIMYCOTIC AGENTS OXFORD GLYCOSCIENCES (UK) LIMITED (GB) 2002-03-07 WO disclosed